Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Charles River Laboratories (CRL) Common Stock USD0.01

Sell:$270.89 Buy:$270.96 Change: $9.19 (3.20%)
Market closed |  Prices as at close on 8 March 2021 | Switch to live prices |
Sell:$270.89
Buy:$270.96
Change: $9.19 (3.20%)
Market closed |  Prices as at close on 8 March 2021 | Switch to live prices |
Sell:$270.89
Buy:$270.96
Change: $9.19 (3.20%)
Market closed |  Prices as at close on 8 March 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Charles River Laboratories International, Inc. is an early-stage contract research company. The Company is engaged in laboratory animal medicine and science (research model technologies) and develop a portfolio of discovery and safety assessment services, both good laboratory practice (GLP) and non-GLP, which supports its clients from target identification through non-clinical development. The Company operates in three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment includes Research Models and Research Model Services. The DSA segment includes Discovery Services and Safety Assessment. The Manufacturing segment includes Microbial Solutions, Avian, Biologics and Contract Manufacturing. The Company also provides a suite of products and services to support the Company's clients' manufacturing activities.

Contact details

Address:
251 Ballardvale St
WILMINGTON
01887-1096
United States
Telephone:
+1 (781) 2226000
Website:
https://www.criver.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
CRL
ISIN:
US1598641074
Market cap:
$13.63 billion
Shares in issue:
49.78 million
Sector:
Life Sciences Tools & Services
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • James Foster
    Chairman of the Board, President, Chief Executive Officer
  • David Smith
    Chief Financial Officer, Corporate Executive Vice President
  • William Barbo
    Corporate Executive Vice President and Chief Commercial Officer
  • Birgit Girshick
    Corporate Executive Vice President, Global Discovery and Safety Assessment, Biologics and Avian
  • Joseph LaPlume
    Corporate Executive Vice President, Corporate Development and Strategy

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.